Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions

被引:48
作者
Aberle, SW
Kletzmayr, J
Watschinger, B
Schmied, B
Vetter, N
Puchhammer-Stöckl, E
机构
[1] Univ Vienna, Inst Virol, A-1095 Vienna, Austria
[2] Univ Vienna, Dept Med, Div Nephrol & Dialysis, A-1095 Vienna, Austria
[3] Pulmol Zentrum, Vienna, Austria
关键词
D O I
10.1128/JCM.39.5.1972-1974.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A line probe assay (INNO-LiPA HBV BR) detecting drug-resistant hepatitis B virus (HBV) strains was evaluated, Results concordant with sequence analysis were obtained with 48 of 56 serum samples from HBV-infected patients undergoing lamivudine therapy. In eight cases, additional minor subpopulations could be identified by the line probe assay.
引用
收藏
页码:1972 / 1974
页数:3
相关论文
共 15 条
[1]   Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine [J].
Allen, MI ;
Gauthier, J ;
DesLauriers, M ;
Bourne, EJ ;
Carrick, KM ;
Baldanti, F ;
Ross, LL ;
Lutz, MW ;
Condreay, LD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) :3338-3347
[2]   Identification and characterization of mutations in hepatitis B virus resistant to lamivudine [J].
Allen, MI ;
Deslauriers, M ;
Andrews, CW ;
Tipples, GA ;
Walters, KA ;
Tyrrell, DLJ ;
Brown, N ;
Condreay, LD .
HEPATOLOGY, 1998, 27 (06) :1670-1677
[3]   Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].
Bartholomew, MM ;
Jansen, RW ;
Jeffers, LJ ;
Reddy, KR ;
Johnson, LC ;
Bunzendahl, H ;
Condreay, LD ;
Tzakis, AG ;
Schiff, ER ;
Brown, NA .
LANCET, 1997, 349 (9044) :20-22
[4]  
Colledge D, 1997, HEPATOLOGY, V26, P216
[5]   A one-year trial of lamivudine for chronic hepatitis B [J].
Lai, CL ;
Chien, RN ;
Leung, NWY ;
Chang, TT ;
Guan, R ;
Tai, DI ;
Ng, KY ;
Wu, PC ;
Dent, JC ;
Barber, J ;
Stephenson, SL ;
Gray, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (02) :61-68
[6]   Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine [J].
Ling, R ;
Mutimer, D ;
Ahmed, N ;
Boxall, EH ;
Elias, E ;
Dusheiko, GM ;
Harrison, TJ .
HEPATOLOGY, 1996, 24 (03) :711-713
[7]   A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection [J].
Main, J ;
Brown, JL ;
Howells, C ;
Galassini, R ;
Crossey, M ;
Karayiannis, P ;
Georgiou, P ;
Atkinson, G ;
Thomas, HC .
JOURNAL OF VIRAL HEPATITIS, 1996, 3 (04) :211-215
[8]   Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment [J].
Niesters, HGM ;
Honkoop, P ;
Haagsma, EB ;
de Man, RA ;
Schalm, SW ;
Osterhaus, ADME .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1382-1385
[9]   Multicenter study of lamivudine therapy for hepatitis B after liver transplantation [J].
Perrillo, R ;
Rakela, J ;
Dienstag, J ;
Levy, G ;
Martin, P ;
Wright, T ;
Caldwell, S ;
Schiff, E ;
Gish, R ;
Villeneuve, JP ;
Farr, G ;
Anschuetz, G ;
Crowther, L ;
Brown, N .
HEPATOLOGY, 1999, 29 (05) :1581-1586
[10]   Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy [J].
Puchhammer-Stöckl, E ;
Mandl, CW ;
Kletzmayr, J ;
Holzmann, H ;
Hofmann, A ;
Aberle, SW ;
Heinz, FX ;
Watschinger, B ;
Hofmann, H .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :2063-2066